MetaVia
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
545 Concord Ave Ste 210, Cambridge, Mass...Phone Number
(857) 702-9600Website
www.metaviatx.comRevenue
-Stock Symbol
MTVAIndustry
ZI Rank: 1
About MetaVia
MetaVia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MetaVia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on MetaVia recently announced quarterly report
MetaVia, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at MetaVia
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if MetaVia has recently received funding, and reach out quickly before it becomes old news!
Check out if MetaVia is spiking on competitors!
Funding: Get notified immidiatlly once MetaVia has new funding data
Product Launch: Get notified when MetaVia launches new products
Click to see if MetaVia had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at MetaVia
Find 3 more new buyers
Company Profile Activity
Activity Insights
MetaVia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MetaVia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MetaVia.
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MetaVia
MetaVia formerly known as NeuroBo Pharmaceuticals is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing DA-1726 for the treatment of obesity and DA-1241 for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH).... Read More
